Victory Capital Management Inc Cytek Biosciences, Inc. Transaction History
Victory Capital Management Inc
- $99 Billion
- Q3 2024
A detailed history of Victory Capital Management Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 22,745 shares of CTKB stock, worth $130,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,745
Previous 23,000
1.11%
Holding current value
$130,556
Previous $128,000
1.56%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CTKB
# of Institutions
135Shares Held
71.7MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$67.6 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$54.5 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$38.2 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$23.9 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $773M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...